Procept Stock Based Compensation from 2010 to 2026

PRCT Stock

USD 28.09 0.41 1.44%

Procept Biorobotics Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2026. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2020-03-31

Previous Quarter

12.2 M

Current Value

14.5 M

Quarterly Volatility

4.1 M

Covid

Interest Hikes

Check Procept Biorobotics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procept Biorobotics' main balance sheet or income statement drivers, such as Net Interest Income of 8.1 M, Interest Income of 13.2 M or Depreciation And Amortization of 3.6 M, as well as many indicators such as Price To Sales Ratio of 20.42, Dividend Yield of 0.0 or PTB Ratio of 18.47. Procept financial statements analysis is a perfect complement when working with Procept Biorobotics Valuation or Volatility modules.

Build AI portfolio with Procept Stock

Check out the analysis of Procept Biorobotics Correlation against competitors.

The evolution of Stock Based Compensation for Procept Biorobotics Corp provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Procept Biorobotics compares to historical norms and industry peers.

Latest Procept Biorobotics' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Procept Biorobotics Corp over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Procept Biorobotics' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Procept Biorobotics' overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Procept Stock Based Compensation Regression Statistics

	Arithmetic Mean	9,546,047
	Geometric Mean	4,354,141
	Coefficient Of Variation	138.96
	Mean Deviation	10,428,655
	Median	1,994,000
	Standard Deviation	13,265,014
	Sample Variance	176T
	Range	36.5M
	R-Value	0.78
	Mean Square Error	73T
	R-Squared	0.61
	Significance	0.0002
	Slope	2,053,648
	Total Sum of Squares	2815.4T

Procept Stock Based Compensation History

	2026	38.4 M
	2025	36.6 M
	2024	31.8 M
	2023	19.1 M
	2022	10.3 M
	2021	3.8 M
	2020	2.2 M

Other Fundumenentals of Procept Biorobotics Corp

Stock Based Compensation To Revenue

Procept Biorobotics Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Short Term Debt	Intangible Assets	Property Plant Equipment	Short Long Term Debt	Capital Surpluse	Deferred Long Term Liab	Common Stock
Total Assets		0.93	0.91	0.87	-0.93	-0.94	0.89	0.93	0.85	0.97	0.94	1.0	1.0	-0.59	-0.98	0.86	-0.43	-0.43	-0.43	0.61
Total Stockholder Equity	0.93		0.92	0.96	-0.96	-0.96	0.81	0.89	0.94	0.9	0.99	0.93	0.93	-0.58	-0.95	0.9	-0.7	-0.7	-0.7	0.69
Net Tangible Assets	0.91	0.92		0.79	-0.97	-0.89	0.81	0.9	0.76	0.88	0.97	0.91	0.92	-0.69	-0.9	0.82	-0.49	-0.49	-0.49	0.49
Current Deferred Revenue	0.87	0.96	0.79		-0.84	-0.96	0.82	0.78	1.0	0.87	0.92	0.87	0.86	-0.54	-0.92	0.93	-0.75	-0.75	-0.75	0.75
Net Debt	-0.93	-0.96	-0.97	-0.84		0.91	-0.76	-0.92	-0.81	-0.88	-0.98	-0.94	-0.95	0.59	0.92	-0.81	0.52	0.52	0.52	-0.52
Retained Earnings	-0.94	-0.96	-0.89	-0.96	0.91		-0.91	-0.89	-0.94	-0.95	-0.96	-0.93	-0.92	0.56	0.98	-0.96	0.59	0.59	0.59	-0.58
Accounts Payable	0.89	0.81	0.81	0.82	-0.76	-0.91		0.82	0.79	0.94	0.84	0.87	0.85	-0.62	-0.93	0.92	-0.36	-0.36	-0.36	0.49
Long Term Debt	0.93	0.89	0.9	0.78	-0.92	-0.89	0.82		0.75	0.95	0.91	0.93	0.93	-0.37	-0.93	0.85	-0.45	-0.45	-0.45	0.53
Net Receivables	0.85	0.94	0.76	1.0	-0.81	-0.94	0.79	0.75		0.84	0.9	0.84	0.84	-0.52	-0.9	0.9	-0.76	-0.76	-0.76	0.75
Total Liab	0.97	0.9	0.88	0.87	-0.88	-0.95	0.94	0.95	0.84		0.91	0.96	0.95	-0.51	-0.99	0.93	-0.44	-0.44	-0.44	0.58
Net Invested Capital	0.94	0.99	0.97	0.92	-0.98	-0.96	0.84	0.91	0.9	0.91		0.94	0.95	-0.65	-0.95	0.9	-0.63	-0.63	-0.63	0.63
Total Current Assets	1.0	0.93	0.91	0.87	-0.94	-0.93	0.87	0.93	0.84	0.96	0.94		1.0	-0.59	-0.98	0.85	-0.43	-0.43	-0.43	0.61
Net Working Capital	1.0	0.93	0.92	0.86	-0.95	-0.92	0.85	0.93	0.84	0.95	0.95	1.0		-0.59	-0.97	0.83	-0.43	-0.43	-0.43	0.61
Short Term Debt	-0.59	-0.58	-0.69	-0.54	0.59	0.56	-0.62	-0.37	-0.52	-0.51	-0.65	-0.59	-0.59		0.56	-0.51	0.27	0.27	0.27	-0.33
Intangible Assets	-0.98	-0.95	-0.9	-0.92	0.92	0.98	-0.93	-0.93	-0.9	-0.99	-0.95	-0.98	-0.97	0.56		-0.94	0.5	0.5	0.5	-0.6
Property Plant Equipment	0.86	0.9	0.82	0.93	-0.81	-0.96	0.92	0.85	0.9	0.93	0.9	0.85	0.83	-0.51	-0.94		-0.63	-0.63	-0.63	0.63
Short Long Term Debt	-0.43	-0.7	-0.49	-0.75	0.52	0.59	-0.36	-0.45	-0.76	-0.44	-0.63	-0.43	-0.43	0.27	0.5	-0.63		1.0	1.0	-0.8
Capital Surpluse	-0.43	-0.7	-0.49	-0.75	0.52	0.59	-0.36	-0.45	-0.76	-0.44	-0.63	-0.43	-0.43	0.27	0.5	-0.63	1.0		1.0	-0.8
Deferred Long Term Liab	-0.43	-0.7	-0.49	-0.75	0.52	0.59	-0.36	-0.45	-0.76	-0.44	-0.63	-0.43	-0.43	0.27	0.5	-0.63	1.0	1.0		-0.8
Common Stock	0.61	0.69	0.49	0.75	-0.52	-0.58	0.49	0.53	0.75	0.58	0.63	0.61	0.61	-0.33	-0.6	0.63	-0.8	-0.8	-0.8

Click cells to compare fundamentals

About Procept Biorobotics Financial Statements

Procept Biorobotics shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Procept Biorobotics investors may analyze each financial statement separately, they are all interrelated. The changes in Procept Biorobotics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Procept Biorobotics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Stock Based Compensation	36.6 M	38.4 M
Stock Based Compensation To Revenue	0.16	0.21

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Procept Stock Analysis

When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Procept Stock Based Compensation from 2010 to 2026

Latest Procept Biorobotics' Stock Based Compensation Growth Pattern

Procept Stock Based Compensation Regression Statistics

Procept Stock Based Compensation History

Other Fundumenentals of Procept Biorobotics Corp

Procept Biorobotics Stock Based Compensation component correlations

About Procept Biorobotics Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Procept Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY